SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-17-004625
Filing Date
2017-08-02
Accepted
2017-08-02 17:01:54
Documents
1
Period of Report
2017-07-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4_dgoldenberg080217.html 4  
1 OWNERSHIP DOCUMENT f4_dgoldenberg080217.xml 4 7417
  Complete submission text file 0001171843-17-004625.txt   8797
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Issuer) CIK: 0000722830 (see all company filings)

IRS No.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address UBS GLOBAL ASSET MANAGEMENT (US) INC. 51 WEST 52ND STREET NEW YORK NY 10019
Business Address
GOLDENBERG DAVID M (Reporting) CIK: 0001029578 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12104 | Film No.: 171001014